Medigene AG (MDGEF) Q2 2024 Earnings Call Transcript [Seeking Alpha]
Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.adaptimmune.com/phoenix.zhtml?c=253991&p=irol-newsarticle&id=2255800
Company Research
Source: Seeking Alpha
Follow Play Earnings Call Medigene AG ( OTCPK:MDGEF ) Q2 2024 Earnings Conference Call August 14, 2024 9:30 AM ET Company Participants Pamela Keck - Head, IR Selwyn Ho - CEO Conference Call Participants Joe Pantginis - H.C. Wainwright Abhishek Raval - AlphaValue Operator Ladies and gentlemen, thank you for standing by. Welcome to the Medigene AG Half Year 2024 Earnings Call and Live Webcast. [Operator Instructions] The conference must not be recorded for publication. At this time, it's my pleasure to hand over to Pamela Keck. Please go ahead. Pamela Keck Welcome, everyone, and thank you for joining us. With me today is Dr. Selwyn Ho, CEO of Medigene. Today, we announced financial results for the 6 months ended June 30, 2024. You can access the press release on the Investor Relations page on our website at medigene.com. Before we get started, let's quickly run through the forward-looking statements. Please note that as part of our discussion today, manageme
Show less
Read more
Impact Snapshot
Event Time:
ADAP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADAP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADAP alerts
High impacting Adaptimmune Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ADAP
News
- Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to LondonPR Newswire
- Adaptimmune Therapeutics (NASDAQ:ADAP) investors are sitting on a loss of 74% if they invested three years ago [Yahoo! Finance]Yahoo! Finance
- Adaptimmune Therapeutics plc (NASDAQ: ADAP) was upgraded by analysts at StockNews.com from a "hold" rating to a "strong-buy" rating.MarketBeat
- Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.MarketBeat
- Thermo Fisher's (TMO) CDx Gets FDA's Nod for Synovial Sarcoma [Yahoo! Finance]Yahoo! Finance
ADAP
Sec Filings
- 8/12/24 - Form 10-Q
- 8/12/24 - Form 8-K
- 8/2/24 - Form 8-K
- ADAP's page on the SEC website